Mode
Text Size
Log in / Sign up
Phase 3 N=59,721 Randomized Triple-blind Prevention

Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh

Vitamin A Deficiency · Maternal Mortality · Infant Mortality

Enrolled (actual)
59,721
Serious AEs
Results posted
Oct 2011
Primary outcome: Primary: All-cause, Pregnancy-related Mortality — 41; 47; 50 Participants — p=0.05

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Vitamin A or Beta-Carotene Supplements (Dietary_supplement)
Age
Pediatric, Adult · 15+ yrs
Sex
Female
Sponsor
Johns Hopkins Bloomberg School of Public Health
Primary completion
Jan 2007

Outcome Measures

OutcomeResultp-value
PRIMARY
All-cause, Pregnancy-related Mortality
41; 47; 50 0.05
SECONDARY
All-cause 3-month Infant Mortality
951; 904; 979
SECONDARY
Maternal Morbidity, Including Obstetric Complications
SECONDARY
Gestational Age at Birth
SECONDARY
Fetal Growth and Postnatal Infant Growth Through Three Months of Age
SECONDARY
Infant Morbidity Through 3 Months of Age
SECONDARY
Plasma Beta-carotene in the Third Trimester of Pregnancy(Nutritonal Status of the Mother)
0.11; 0.12; 0.12
SECONDARY
Plasma Retinol at the Third Trimester of Pregnancy (Nutritional Status of the Mother)
1.02; 1.25; 1.06

Summary

The purpose of this trial is to determine whether providing women with a weekly oral supplement of vitamin A, either preformed or as beta-carotene, at a dosage equivalent to a recommended intake from early pregnancy through three months postpartum, can reduce the risk of maternal mortality, fetal loss, or infant mortality.

Eligibility Criteria

Inclusion Criteria

  • Married women of reproductive age
  • First pregnancy during time period of trial

Exclusion Criteria

  • Premenarchial girls
  • Married women with a previous pregnancy enrolled into the trial
  • Previously married women who have moved into the study area
  • Single women (never married, widowers)
  • Women who are sterilized (or whose husbands are sterilized)
  • Menopausal women
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00198822). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search